Change font size Change contrast


Oxular’s product development pipeline includes treatments for both prevalent retinal diseases, such as age-related macular degeneration and diabetic macular oedema, as well as rare and orphan conditions.

Our unique approach aims to increase therapeutic effectiveness, reduce side effects and minimise frequency of retinal treatments.

Find out more about us